Imaging with CT and coronary CT angiography shows prevalent and extensive presence of coronary artery plaque among men infected with HIV.
Computed tomography (CT) and coronary CT angiography detect noncalcified coronary artery plaque in HIV-infected men, regardless of cardiac risk factors, according to a study published in the Annals of Internal Medicine.
Researchers from Maryland, California, Pennsylvania and Illinois undertook a cross-sectional study to determine whether men infected with HIV have more coronary atherosclerosis tha[[{"type":"media","view_mode":"media_crop","fid":"23820","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4079388160591","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1978","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 200px; width: 267px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]n men without the virus. Data were obtained from the Multicenter AIDS Cohort Study (MACS).
A total of 1001 men, ages 40 to 70, who had sex with men were assessed; 618 were infected with HIV and 383 were not. None had any history of coronary revascularization. Noncontrast cardiac CT, performed on all men, was used to assess for the presence and extent of coronary artery calcium (CAC). Of this group, 759 also underwent coronary CT angiography to assess for any plaque, noncalcified, mixed or calcified plaque; or stenosis.
The researchers found that the HIV-infected men had a greater prevalence of CAC and any plaque, including noncalcified and mixed plaque, than the uninfected men. The association between HIV infection and any plaque or noncalcified plaque remained significant after CAD risk factor adjustment, the authors wrote.
The authors concluded that, “Coronary artery plaque, especially noncalcified plaque, is more prevalent and extensive in HIV-infected men, independent of CAD risk factors.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.